Your session is about to expire
← Back to Search
Study EC + VLNC CC for Nicotine Addiction
N/A
Waitlist Available
Led By Francis McClernon, Ph.D.
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during preference session, approximately 2 hours
Awards & highlights
Study Summary
This trialwill investigate how reducing nicotine in cigarettes affects smokers' choices between regular cigarettes & e-cigarettes.
Eligible Conditions
- Nicotine Addiction
- Smoking/Cigarette Smoking
- Electronic Cigarette Use
- Smoking
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ during preference session, approximately 2 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during preference session, approximately 2 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of choices for CC during preference task
Secondary outcome measures
CO boost
Cigarette Evaluation Scale
Craving
+5 moreTrial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Study EC + VLNC CCExperimental Treatment2 Interventions
Participants will make choices between the study EC device with tobacco flavor and the very low nicotine content (VLNC) investigational CC
Group II: Study EC + NNC CCActive Control2 Interventions
Participants will make choices between the study EC device with tobacco flavor and the normal nicotine content (NNC) investigational CC
Group III: Own EC + UB CCActive Control1 Intervention
Participants will make choices between their own EC device with their own tobacco flavor and their UB CC
Group IV: Study EC + UB CCActive Control1 Intervention
Participants will make choices between the study e-cigarette (EC) device with tobacco flavor and their usual brand (UB) combusted cigarette (CC)
Find a Location
Who is running the clinical trial?
National Institute on Drug Abuse (NIDA)NIH
2,464 Previous Clinical Trials
2,618,586 Total Patients Enrolled
15 Trials studying Nicotine Addiction
2,130 Patients Enrolled for Nicotine Addiction
National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,952,581 Total Patients Enrolled
3 Trials studying Nicotine Addiction
327 Patients Enrolled for Nicotine Addiction
Duke UniversityLead Sponsor
2,358 Previous Clinical Trials
3,420,062 Total Patients Enrolled
3 Trials studying Nicotine Addiction
164 Patients Enrolled for Nicotine Addiction
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is recruitment for this medical experiment open at the present time?
"Indeed, clinicaltrials.gov indicates that this research project is currently open for recruitment; the trial was first publicized on October 12th 2022 and has since been updated on November 28th 2022."
Answered by AI
What is the current anticipated enrollment for this clinical experiment?
"Affirmative. Clinicaltrials.gov's information indicates that this clinical trial is currently recruiting participants, first posted on the 12th of October and last updated November 28th 2022. The research seeks 36 individuals to be involved in a single site study."
Answered by AI
Who else is applying?
What state do they live in?
Texas
What portion of applicants met pre-screening criteria?
Did not meet criteria
Share this study with friends
Copy Link
Messenger